FDA Postpones Approval of Natural Food Dyes Amid Safety Concerns
FDA delays two ‘natural’ food dyes after safety concerns

Image: Food & Drink International
The U.S. Food and Drug Administration (FDA) has postponed the approval of two food colorings, beetroot red and spirulina extract, due to safety testing objections. This decision comes as the FDA encourages food manufacturers to eliminate artificial colors and raises concerns about carcinogenic risks and heavy metal exposure associated with these dyes.
- 01FDA delays approval of beetroot red and spirulina extract due to safety concerns.
- 02Critics argue that safety checks for these dyes were incomplete.
- 03Concerns include potential carcinogenic risks and heavy metal exposure.
- 04FDA plans to revise approval processes and lower heavy metal thresholds.
- 05Food manufacturers face legal risks if safety and labeling issues are not resolved.
Advertisement
In-Article Ad
The U.S. Food and Drug Administration (FDA) has delayed the approval of two food colorings marketed as natural, beetroot red and spirulina extract, following safety concerns raised by industry groups and advocacy organizations. These groups argue that essential safety tests were not conducted, particularly regarding long-term carcinogenic risks and heavy metal exposure. Critics pointed out that the FDA's assessment of spirulina extract did not consider cumulative exposure from various food sources, and the proposed arsenic limits for this dye were significantly higher than those for other products like apple juice. In response to these objections, the FDA plans to revise its approval process for spirulina extract and lower the permissible thresholds for heavy metals. Additionally, the production method of beetroot red, which involves fermentation rather than direct extraction, has raised questions about its classification as a natural product. This delay underscores the challenges food companies face in transitioning away from synthetic dyes, with experts warning of potential legal risks, including consumer lawsuits, if safety and labeling concerns are not adequately addressed.
Advertisement
In-Article Ad
This delay may affect food manufacturers' product offerings and labeling practices, potentially leading to legal challenges if safety concerns are not addressed.
Advertisement
In-Article Ad
Reader Poll
Do you think the FDA should approve natural food dyes despite safety concerns?
Connecting to poll...
More about U.S. Food and Drug Administration
Granules India Enhances Oversight Following US FDA Warning
The Economic Times • Apr 9, 2026

Glenmark Pharmaceuticals Secures USFDA Approval for Progesterone Vaginal Inserts
Business Standard • Apr 9, 2026

Biocon Pharma Secures USFDA Approval for Dapagliflozin Tablets to Aid Diabetes Treatment
Business Standard • Apr 8, 2026
Read the original article
Visit the source for the complete story.




